1型糖尿病儿童使用N95口罩:是否会影响临床结果?
Gül Trabzon1, Şeyma Demiray Güllü2, Şükrü Güngör3
1Mustafa Kemal University, Medical Faculty, Department of Pediatric Endocrinology, Hatay, Turkey.
Journal of pediatric nursing
|March 12, 2025
概括
在患有1型糖尿病 (T1DM) 的儿童中使用N95口罩可能会引起不适,但不会显著改变生理参数. 需要进一步的研究来证实这些发现,N95口罩对儿科T1DM患者的影响.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 传染病控制和控制传染病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 随着COVID-19的流行,N95口罩的使用变得越来越普遍.
- N95口罩对1型糖尿病 (T1DM) 的儿童的影响尚不清楚.
研究的目的:
- 研究N95口罩使用对T1DM儿科患者临床结果的影响.
主要方法:
- 34名患有T1DM的儿童 (年龄在10-18岁) 参与了这项研究.
- 在使用N95口罩1小时之前和之后评估症状和生理参数.
- 测量血糖和毛细血管血液气体水平.
主要成果:
- 47%的参与者报告了不适,包括呼吸困难 (41.2%) 和耳朵疼痛 (26.5%).
- 没有观察到血糖,生命体征或血液气体参数的显著变化.
- 尽管报告了症状,但实验室值和生理参数保持稳定.
结论:
- N95口罩可能会引起T1DM儿童的不适,但不会对生理参数产生负面影响.
- 将口罩引起的不适与保护性益处相平衡至关重要.
- 建议进行进一步的研究,使用更长的N95口罩使用时间.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Insulin: Dosing Regimen and Adverse Effects
135
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
135
Pathophysiology of Diabetes
839
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Diabetes: Management and Pharmacotherapy
220
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220


